• Home
  • About IFBLS
    • History
    • IFBLS Mission and Objectives
    • IFBLS By-Laws
    • IFBLS Strategic Plan
    • President's welcome
    • IFBLS Board of Directors
    • IFBLS Board Committee Structure
    • Election of IFBLS Board of Directors 2026 - 2028
    • General Assembly of Delegates (GAD)
    • Alternate GAD and Chief Delegates Meeting (AltGAD) (
    • International Journal of Biomedical Laboratory Science (IJBLS)
    • IFBLS Scientific Network of Experts (SNE)
    • Britta Karlsson Educational Webinar Series
    • Britta Karlsson Advancement Program
    • International Directory of Biomedical Laboratory Science Education
    • International Biomedical Laboratory Science Day (BLS Day)
      • International BLS Day Themes
    • Collaborations
    • Advisory Groups
    • e Learning
    • IFBLS Newsletters
    • In Memoriam
    • Announcements
  • Membership
    • Membership Benefits
    • Application
    • Members
    • Collaboration Project
    • Members Login
  • Statements
    • Code of Ethics
    • Core Competence
    • Point of Care Testing (POCT)
    • Patient Safety
    • Role of BLS in the Delivery of Quality Healthcare
    • WHO Statements
    • COVID-19 Resources
  • Congress
    • 37th IFBLS World Congress
    • Planned Congresses
    • Past Congresses
    • Information & Application
  • Awards
    • Awards Program 2026
    • IFBLS Fellowship Award
    • TMER Award
    • Past Award Winners 2008-2026
    • TMER Overseas Training Project 2024 - Interview
  • What's New
    • IFBLS World Congress 2026
    • IFBLS World Congress 2028
    • IFBLS Scientific Network of Experts
    • IJBLS Journal - Latest Issue
    • Fellows of IFBLS - FIFBLS
    • Meet the IFBLS Board
    • International BLS Day 2026
    • IFBLS 70th Anniversary
    • TMER Overseas Training Project 2024 - Interview
    • IFBLS Alternate GAD 2025 - Stockholm Sweden
  • Contact
    • Office and Contact Information

WHO STATEMENTS

Details
Super User
Statements
WHO Statements
Last Updated: 20 March 2025
Hits: 19324

WHO Collaboration

We are thrilled to announce that at the 156th WHO Executive Board Meeting in February 2025, IFBLS received approval to continue as a Non-State Actor in Official Relations with the World Health Organization (WHO) for another three years.

This achievement reflects the strength of our ongoing partnership and the extensive collaboration that went into developing the IFBLS-WHO Triennial Workplan for 2025–2027. We are especially pleased to be working closely with Dr. Ana Aceves Capri, Technical Officer at the WHO in Geneva, Switzerland, as we advance our shared goals in global health.

We look forward to a productive and impactful collaboration in the years ahead!

 

Statements:

 To see the statement submitted by IFBLS to the WHO Special session of the Executive Board in October 2020 click below:

  • IFBLS Statement on implementation of WHA73.1 (2020) on the COVID-19 response


To see the statement submitted by IFBLS to the 146th WHO Executive Board in February 2020 click below:

  • IFBLS Statement on Accelerating Cervical Cancer Elimination 146th WHO Executive Board February 2020
    IFBLS Oral Statement on Accelerating Cervical Cancer Elimination 146th WHO Executive Board February 2020

To see the statement submitted by IFBLS to the 73rd World Health Assembly in May 2020 click below:

  • IFBLS Statement on COVID-19 Pandemic Response for the 73rd World Health Assembly May 2020

 
To see the statements submitted by IFBLS to the 144th WHO Executive Board in January 2019 click below:

  • IFBLS Statement on Accelerating Cervical Cancer Elimination 144th WHO Executive Board January 2019
  • IFBLS Statement on Antimicrobial Resistance 144th WHO Executive Board January 2019
  • IFBLS Statement on Human Resources for Health 144th WHO Executive Board January 2019
  • IFBLS Statement on Non-Communicable Diseases 144th WHO Executive Board January 2019
  • To see the video statement delivered by President-Elect Alan Wainwright on the Prevention and Control of Non-Communicable Diseases at the 144th WHO Executive Board in January 2019 click here.
 
To see the statement President Marie Nora Roald made at the 140th WHO Executive Board in January 2017 click here.
To see the statement President Tom Stowe made at the 138th WHO Executive Board in January 2016 click here.
 
 
 

WHO STATEMENTS

Details
Super User
Statements
WHO Statements
Last Updated: 11 February 2019
Hits: 2621

In January 2016 IFBLS was assigned a new Designated Technical Officer (DTO); Adriana Velazquez-Berumen.

IFBLS has been working extensively to prepare the IFBLS – WHO Collaboration plan for 2017 – 2019.

The 140th WHO Executive Board in January 2017 decided to maintain WHO’s Official Relations with IFBLS.

To see the statement President Marie Nora Roald made at the 140th WHO Executive Board in January 2017 click here.

To see the statement President Tom Stowe made at the 138th WHO Executive Board in January 2016 click here.

IFBLS Office Contact Information

E-mail: communications@ifbls.org

Telephone: 001 905 667 8695

IFBLS
33 Wellington Street North
Hamilton, Ontario  L8R 1M7
CANADA

The global voice of Biomedical Laboratory Scientists

The International Federation of Biomedical Laboratory Science (est. 1954) is the world's widest reaching international organization for Biomedical Laboratory Scientists, bringing the profession, the professionals and health priorities to the world stage.


Join us on Social Media!   Facebook png  Linkedin png  Instagram png  YouTube png 

Copyright © 2026 IFBLS. All Rights Reserved.
Joomla! is Free Software released under the GNU General Public License.
  • About us
  • Author Login
  • Contact Us
  • Privacy